Drug intelligence / Profile preview

clobetasol propionate + retapamulin

Development stage
Unknown
Lead developer
Formosa Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Topical
01

Overview

Clobetasol propionate + retapamulin is a topical combination drug consisting of two active ingredients with complementary mechanisms for the treatment of skin conditions. Clobetasol propionate is a potent synthetic corticosteroid that acts as an anti-inflammatory and immunosuppressive agent by binding to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory gene expression. It reduces swelling, redness, itching, and rashes associated with various dermatoses[2][7][8][9]. Retapamulin is a semisynthetic pleuromutilin antibiotic that selectively inhibits bacterial protein synthesis at the level of the 50S ribosomal subunit, making it effective against certain Gram-positive bacteria such as Staphylococcus aureus (methicillin-susceptible) and Streptococcus pyogenes[1][4][6][10]. The combination may be used for inflammatory skin conditions complicated by or at risk for secondary bacterial infection.

02

Targets

GR (Glucocorticoid receptor)Bacterial 50S ribosomal subunit

Beyond the preview

Go deeper on clobetasol propionate + retapamulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasol propionate + retapamulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call